Documents and Sources

These records illuminate the controversy. None is, by itself, clinical proof that the regimen works.

Reading rule: identify who created a source, what question it addressed, what evidence it used, and what it cannot establish.

Legal and regulatory record

Hoxsey v. Fishbein (1949)

A libel action ending in nominal damages. It did not test treatment efficacy.

United States v. Hoxsey Cancer Clinic (1952)

The Fifth Circuit held the efficacy representations false and misleading on the record and directed an injunction. This is essential context for the later advocacy documents.

FDA “Public Beware” warning (1956)

A regulator's public warning and an artifact of the federal enforcement campaign.

Political and advocacy documents

Fitzgerald memorandum (1953)

Special counsel Benedict Fitzgerald's allegations about cancer-research institutions. Its appearance in the Congressional Record did not turn the allegations into congressional findings or clinical evidence.

Visiting physicians' report (1954)

A short clinic visit and endorsement without a controlled design, independent outcome verification, or adequate follow-up.

Government and medical reviews

Source labels

Autobiographies, documentaries, and testimonials are useful for understanding experience and advocacy. Court opinions establish legal holdings. Laboratory studies test mechanisms. Controlled clinical studies test patient outcomes. This archive does not collapse those categories.